Therapies and Diagnostics for Ovarian Cancer Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2016 – 2025
Report Description
Global Therapies and Diagnostics for Ovarian Cancer Market is expected to grow at CAGR of 7.2% from 2017 to 2025. The report highlights the key trends, market outlook and the global scenario of the Global Therapies and Diagnostics for Ovarian Cancer Market. The market sizing is provided from 2016 to 2025, wherein the forecast is provided from 2017 to 2025. In addition, market dynamics (i.e. market drivers, market restraints and market opportunities) which covers factors supporting the market growth, factors restraining the market growth and factors behind the opportunities across this industry in the coming years has been included extensively under the scope of the study. The report also provides extensive detail of the market segments across type, application, and geography; market share of the key players globally and the competitive scenario throughout the forecast period, industry expert opinion, and profiles of the key players in the market.
The major key players of the market are as follows:
KEY PLAYERS
ABBVIE INC.
ASTRA ZENECA
BRISTOL-MYERS SQUIBB
CELGENE CORP.
CLOVIS ONCOLOGY
ELI LILLY AND COMPANY
GLAXOSMITHKLINE PLC
HIKMA PHARMACEUTICALS PLC
JANSSEN PHARMACEUTICALS, INC.
MERCK & CO., INC.
MYRIAD GENETICS INC.
NOVARTIS AG
PFIZER INC.
QUEST DIAGNOSTICS INC.
ROCHE HOLDING AG
TESARO, INC.
Scope of the Market
Diagnosis Market
Cancer Type Market
Epithelial Ovarian Tumors
Germ Cell Tumors
Stromal Tumors
Primary Peritoneal Cancer
Stages of Ovarian Cancer
Prognosis
Geography Market
North America
Europe
Asia Pacific
Rest of the World (RoW)
Payment Options